glp-1 market news today Growth: Projected to Reach $95.4 Million by 2031 with 10.3% CAGR Market Overview: GLP-1 Agonists and
Description
Novo-Nordisk A/S, Eli Lilly And Company, Sanofi, AstraZeneca, Pfizer Inc., Amgen, Inc., and Innovent Biologics, Inc
The GLP-1 NAION vision-loss MDL hit 146 cases on the July JPML report up 70% in two months as the GI-injury MDL heads to Rule 702 hearings September 10-18.
Indias pharma industry is strong
It is not medical advice
Enjoy natural weight management benefits
